<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03383666</url>
  </required_header>
  <id_info>
    <org_study_id>CSC_2017-01</org_study_id>
    <nct_id>NCT03383666</nct_id>
  </id_info>
  <brief_title>A Study Evaluating the Safety and Effectiveness of the PulseRider® Aneurysm Neck Reconstruction Device Used in Conjunction With Endovascular Coil Embolization in the Treatment of Wide-Neck Bifurcation Intracranial Aneurysm</brief_title>
  <acronym>NAPA</acronym>
  <official_title>A Prospective, Multi-center, Single Arm Study to Evaluate the Safety and Effectiveness of the PulseRider® Aneurysm Neck Reconstruction Device Used in Conjunction With Endovascular Coil Embolization in the Treatment of Wide-Neck Bifurcation Intracranial Aneurysm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pulsar Vascular</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Pulsar Vascular</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, multi-center, non-randomized clinical evaluation utilizing the&#xD;
      PulseRider® Aneurysm Neck Reconstruction Device.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to evaluate the safety and effectiveness of the PulseRider®&#xD;
      Aneurysm Neck Reconstruction Device in conjunction with coil embolization in the endovascular&#xD;
      treatment of unruptured wide-neck intracranial aneurysms.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    No safety issues; change in innovation strategy&#xD;
  </why_stopped>
  <start_date type="Actual">October 15, 2018</start_date>
  <completion_date type="Actual">April 12, 2021</completion_date>
  <primary_completion_date type="Actual">April 12, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Primary Safety Outcome measure is the composite of Neurological Death or Major Ipsilateral Stroke (in downstream territory) up to 1 year post-procedure</measure>
    <time_frame>12 months</time_frame>
    <description>Composite of Neurological Death or Major Ipsilateral Stroke (in downstream territory) up to 1 year post-procedure.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>The primary effectiveness rate of complete aneurysm occlusion without significant parent artery stenosis or prior retreatment at 1 year post-procedure.</measure>
    <time_frame>12 months</time_frame>
    <description>The primary effectiveness rate of complete aneurysm occlusion without significant parent artery stenosis or prior retreatment at 1 year post-procedure.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Technical Success is measured by the successful implantation of the device.</measure>
    <time_frame>Procedural</time_frame>
    <description>The successful implantation of the device.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">21</enrollment>
  <condition>Unruptured Wide-neck Intracranial Aneurysms</condition>
  <arm_group>
    <arm_group_label>Treatment Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>PulseRider® Aneurysm Neck Reconstruction in conjunction with coil embolization for unruptured wide-neck intracranial aneurysms.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>PulseRider® Aneurysm Neck Reconstruction Device</intervention_name>
    <description>Neck Reconstruction Device</description>
    <arm_group_label>Treatment Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Subject with wide neck intracranial aneurysm located at a bifurcation&#xD;
&#xD;
          2. The subject is between 18 and 80 years of age the time of consent&#xD;
&#xD;
          3. Informed consent is obtained and the subject signs the IRB approved consent prior to&#xD;
             beginning any study procedures&#xD;
&#xD;
          4. In the opinion of the treating physician, placement of the PulseRider® device is&#xD;
             technically feasible and clinically indicated&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Unstable neurological deficit (condition worsening within the last 90 days)&#xD;
&#xD;
          2. Subarachnoid Hemorrhage (SAH) within the last 60 days&#xD;
&#xD;
          3. Irreversible bleeding disorder&#xD;
&#xD;
          4. Patient has another intracranial aneurysm that in the Investigator's opinion, may&#xD;
             require treatment within the 1 year follow up period&#xD;
&#xD;
          5. A history of contrast allergy that cannot be medically controlled&#xD;
&#xD;
          6. Known allergy to nickel&#xD;
&#xD;
          7. Relative contraindication to angiography&#xD;
&#xD;
          8. Woman of child-bearing potential who cannot provide a negative pregnancy test&#xD;
&#xD;
          9. Current involvement in a study for another investigational product&#xD;
&#xD;
         10. Patient and / or family considering a move from this geographical location at the time&#xD;
             of consent&#xD;
&#xD;
         11. Categorized as a vulnerable population and require special treatment with respect to&#xD;
             safeguards of well-being (e.g. cognitively impaired, veteran, prisoner, etc.)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Kansas Medical Center</name>
      <address>
        <city>Kansas City</city>
        <state>Kansas</state>
        <zip>66160</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Mount Sinai Hospital</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>December 12, 2017</study_first_submitted>
  <study_first_submitted_qc>December 19, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">December 26, 2017</study_first_posted>
  <last_update_submitted>July 12, 2021</last_update_submitted>
  <last_update_submitted_qc>July 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Unruptured</keyword>
  <keyword>intracranial aneurysms</keyword>
  <keyword>Endovascular</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intracranial Aneurysm</mesh_term>
    <mesh_term>Aneurysm</mesh_term>
  </condition_browse>
  <pending_results>
    <submitted>October 21, 2021</submitted>
    <returned>November 18, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

